A cDNA encoding a novel human extracellularlyregulated kinase (ERK) phosphatase, designated B59, was isolated from a B5/589 human mammary epithelial cell cDNA library. The 1104 nucleotide open reading frame encodes 368 amino acids including the highly conserved catalytic site sequence of protein phosphotyrosine phosphatases (PTPs), VXVHCXXGXXR, at amino acid position 276 ± 287. The predicted 70 amino acid stretch surrounding the HC motif shares signi®cant sequence identity with other human dual speci®city PTPs (dsPTPs), including the known ERK PTPs CL100, PAC1, B23, as well as the dsPTPs VH-1 and VHR. B59 protein synthesized in vitro in a rabbit reticulocyte lysate dephosphorylated rat ERK1 and ERK2 proteins whose phosphorylation had been stimulated by v-mos kinase added to the lysate. Ectopic expression of B59 in NIH3T3 ®broblasts inhibited the induction of an oncogene-responsive promoter by the dominant-activating raf mutant, raf-BXB. Moreover, cotransfection of NIH3T3 cells with B59 inhibited morphological transformation by H-ras and v-raf oncogenes. These results suggest that B59 suppresses the transforming activity of H-ras or v-raf oncogenes through ERK dephosphorylation and inactivation.
Introduction
A subfamily of protein tyrosine phosphatases (PTPs) related to the vaccinia virus-encoded phosphatase VH1 share a characteristic active site sequence VXVHCXXGXXR (known as an`HC motif'; Charbonneau et al., 1989; Krueger et al., 1990) within their catalytic domains, and eciently hydrolyze both phosphotyrosine and phosphoserine (Guan et al., 1991) . Many of these dual-speci®city PTPs (dsPTPs) have been implicated in the regulation of cell proliferation: cdc25 dephosphorylates and activates the cdc2 kinase, stimulating mitosis (Dunphy and Kumagai, 1991; Gautier et al., 1991; Millar et al., 1991) ; KAP/cdil interacts with the cyclin-dependent kinases CDK2 and cdc2 (Hannon et al., 1994; Gyuris et al., 1995) ; and disruption of the yeast VH1 gene results in growth retardation (Guan et al., 1992) . Also among the dsPTPs are CL100 (Alessi et al., 1993) , its mouse homolog 3CH134 (known also as MKP-1; Charles et al., 1992 Charles et al., , 1993 , PAC-1 (Rohan et al., 1993) and B23 (Ishibashi et al., 1994 ) that preferentially dephosphorylate and inactivate extracellular signal-regulated kinase (ERK), a kinase that is activated by phosphorylation on both threonine and tyrosine residues in a TXY motif by ERK kinase, or MEK (reviewed in Marshall, 1995) . The fact that ERK, MEK, and related kinases such as stressactivated protein kinase (SAPK) and the product of the yeast high osmolarity glycerol response gene-1 (p38 HOG1) mediate mitogenesis, dierentiation, and cellular responses to stress (reviewed in Cano and Mahadevan, 1995; Davis, 1994; Cobb and Goldsmith, 1995) suggests that their regulatory dsPTPs also function in these pathways.
We exploited the evolutionary conservation displayed by dsPTPs in the region contiguous with the HC motif to identify new PTPs potentially involved in mitogenic signaling pathways and cell cycle control. By screening a human mammary epithelial cDNA library with a probe spanning part of the 3CH134 catalytic domain under low stringency hybridization conditions, we identi®ed B23, a dsPTP with both structural and functional similarity to the ERK PTPs CL100 and PAC1 (Ishibashi et al., 1994) . Here we report the cDNA cloning of a B23-related PTP, designated B59, using a similar approach. Unlike CL100 and B23, however, the B59 transcript is not induced by serum stimulation or heat shock. B59 protein produced in vitro in a rabbit reticulocyte lysate dephosphorylated rat ERK1 and ERK2 proteins whose phosphorylation had been catalyzed by v-mos kinase added to the lysate. Ectopic expression of B59 in NIH3T3 ®broblasts suppressed the induction of an oncogene-responsive promoter by the dominant-activating raf mutant, raf-BXB. Finally, co-transfection of NIH3T3 cells with B59 suppressed transformation driven by both H-ras and v-raf oncogenes.
Results

Molecular cloning and characterization of a new PTP gene
A 231 bp PCR fragment was generated using primers anking the catalytic domain sequence of the mouse PTP 3CH134 (Charles et al., 1992) . The PCR fragment was radiolabeled and a partial cDNA encoding a novel putative PTP was isolated by screening a human placenta cDNA library with this probe under low stringency hybridization conditions. The cDNA fragment obtained from the placenta library was in turn used to identify a full-length cDNA clone from a B5/ 589 mammary epithelial cell library. Nucleotide sequence analysis of the full-length clone, designated B59, revealed an ATG codon at nucleotides 113 ± 115, followed by a 1104 bp open reading frame. The open reading frame predicts a 368 amino acid polypeptide with a molecular mass of approximately 42 kDa (Figure 1 ). Using a rabbit reticulocyte lysate system, a hemagglutinin (HA) epitope-tagged B59 protein was expressed in vitro and yielded a protein product with a molecular mass consistent with the predicted combined mass of the B59 protein and the HA epitope tag (data not shown). An extended HC motif, the highly conserved active site sequence of PTPs, VSVHCXXGXXRSX-XXXXAY(L/I)M (where X is any amino acid), was present in B59 at amino acid position 276 to 296 (Figure 1a) . The predicted B59 amino acid sequence encompassing this catalytic site (amino acid residues 238 ± 331) showed signi®cant similarity to several known human dsPTPs, including B23, CL100, PAC1, hVH2 (Guan and Butch, 1995; Misra Press et al., 1995) and VHR (Ishibashi et al., 1992) . Among these proteins, the most conserved region lies within a 21-amino acid stretch that includes and (Figure 1b) . N-terminal to this highly conserved region, B59 has a serine-rich sequence (37%; residues 141 ± 189) containing three XSP motifs (residues 143 ± 145, 147 ± 149 and 183 ± 185), which are putative sites for recognition by proline-directed serine kinases (Marshall, 1995) . Further upstream, B59 contains the dual phosphorylation motif TEY (residues 129 ± 131) found in ERK1 and ERK2 that is responsible for the activation of their kinase activities by MEK (reviewed in Marshall, 1995) . While this motif is also found in several proteins that are unlikely to be MEK substrates, its presence in an ERK PTP family member may be signi®cant.
Tissue-speci®c expression of B59 was determined by Northern blot analysis. The major mRNA species observed was approximately 4.0 kb, slightly longer than the longest B59 cDNA isolated from the B5/589 epithelial cell library (Figure 2 ). B59 is expressed in human brain, heart, lung, liver, pancreas, skeletal muscle, kidney and placenta, with the highest level of expression in skeletal muscle (Figure 2 ).
B59 phosphatase dephosphorylates ERKs
The structural similarity of B59 to known ERK PTPs suggested that it also might be an ERK phosphatase. We tested B59 for ERK dephosphorylation activity using B59 protein synthesized in vitro in a rabbit reticulocyte lysate. Xenopus oocyte extracts containing v-mos protein were prepared as a source of activated MEK (Haccard et al., 1995; Pham et al., 1995) . Puri®ed rat ERK1 and ERK2 proteins were added to the activated Xenopus extracts, which resulted in ERK phosphorylation observed indirectly as a retardation of ERK protein migration after SDS ± PAGE and immunoblotting with anti-ERK antibodies ( Figure 3 ). Rabbit reticulocyte lysate containing newly synthesized B59, B23, VHR or 3CH134 was added to extracts containing the phosphorylated rat ERK1 and ERK2 proteins and ERK migration after SDS ± PAGE and immunoblotting was assessed relative to control lysate ( Figure 3 ). No ERK proteins were detectable in control reticulocyte lysates or Xenopus extracts (data not shown). The retarded migration of rat ERK protein was readily detected in the extract containing v-mos protein, suggesting that ERK phosphorylation had been stimulated by v-mos-induced activation of endogenous Xenopus MEK (Figure 3 ). In contrast, ERK1 and ERK2 proteins incubated with rabbit reticulocyte lysate containing B59 were observed in the faster migrating, dephosphorylated form, suggesting that B59 had catalyzed their dephosphorylation ( Figure 3 ). Thus in this assay system, 3CH134, B23 and B59, but not VHR, appear to preferentially dephosphorylate eukaryotically expressed ERKs 1 and 2.
B59 phosphatase regulates transcriptional induction of the AP1 promoter by oncogenic raf
Transcription from the oncogene-responsive element in the polyomavirus enhancer can be activated by serum, phorbol ester and diverse classes of oncogenes (Wasylyk et al., 1988) . The oncogene-responsive element contains an AP-1 binding site and an overlapping Ets-binding site (Bruder et al., 1992) . The pB4X plasmid contains four copies of the oncogeneresponsive element from the polyomavirus enhancer inserted upstream from the b-globin promoter, fused to the chloramphenicol acetyltransferase (CAT) reporter gene. The proto-oncogenes ras and raf-1, or their oncogenic counterparts, transactivate the B4X promoter through AP-1 binding sites but not the Ets1-binding site (Bruder et al., 1992) . To determine whether B59 and related PTPs regulate signal transduction from raf to nuclear onco-proteins, we tested these PTPs for their ability to block the transcriptional activity of the B4X promoter following co-transfection of NIH3T3 fibroblasts with the transforming rafBXB mutant. The rafBXB construct activated the B4X promoter, while co-transfection with a B59 expression plasmid inhibited induction of the B4X promoter by rafBXB (Figure 4 ). 3CH134 and B23 also inhibited induction of the B4X promoter by rafBXB, while in contrast, VHR had no eect on the promoter activity (Figure 4) . Thus, consistent with the results of ERK dephosphorylation assays, B59, B23 and 3CH134 appeared to preferentially block raf signaling, while VHR did not. . dsPTP proteins were synthesized by in vitro transcription-translation as described in Materials and methods. Xenopus protein extract containing v-mos protein was mixed with each lysate in which the indicated PTP or control pCEV27-lacZ plasmid had been expressed. Puri®ed rat ERK1 or ERK2 proteins were added to the reaction mixture and incubated for 20 min at room temperature. The reaction was stopped by boiling in SDSsample buer and the mixtures were separated by SDS ± PAGE, transferred to nitrocellulose membrane, and immunodetected with anti-ERK antibody B59 phosphatase suppresses the transforming activities of H-ras and v-raf oncogenes ERK activation is an immediate consequence of mitogenic stimulation in a variety of cell systems (Blenis, 1993; Cano and Mahadevan, 1995; Davis, 1994; Johnson and Vaillancourt, 1994; Raingeaud et al., 1995) , and several lines of evidence suggest that sustained ERK activation may be required for growth factor-stimulated mitogenesis (Seger and Krebs, 1995; Cowley et al., 1994) . The ras and raf proto-oncogene products appear to be involved in growth factor stimulated mitogenesis downstream of growth factor receptors, and upstream of ERKs, suggesting that sustained ERK activation may also mediate cell transformation by their oncogenic counterparts (Davis, 1995) . Thus it was of interest to test whether B59 and related PTPs could suppress cellular transformation by the H-ras or v-raf oncogene. We co-transfected NIH3T3 cells with various dsPTP expression plasmids and pMMTV-H-ras or pZIP-vraf at a 1 : 1 ratio. Co-transfection of B59 with H-ras or v-raf was associated with a dramatic suppression of focus information induced by either oncogene alone, suggesting that B59 dephosphorylates and inactivates ERK(s) participating in those signal transduction pathways ( Figure 5 ). Two highly related dsPTPs for which ERK dephosphorylation activity has already been reported, 3CH134 and B23 (Ishibashi et al., 1994) , also signi®cantly suppressed cellular transformation by these oncogenes, while VHR had no eect ( Figure 5 ). Quantitative estimates from a series of NIH3T3 transformation assays demonstrated a consistent 70% suppression of H-ras-driven focus formation by B59, B23 and 3CH134, while VHR was consistently without eect under the same assay conditions (Table 1) . Figure 4 The eects of ectopic expression of B59, B23, 3CH134 or VHR on raf-BXB-driven chloramphenicol acetyltransferase (CAT) activity. The oncogene responsive reporter plasmid pB4X was cotransfected with pRSV-rafBXB and each of the indicated dsPTP plasmids (or control plasmid) into NIH3T3 cells. CAT activity was measured using a CAT ELISA kit (Boehringer Mannheim) 48 h after transfection The eects of dsPTPs on v-raf-induced transformation (a ± e) and H-ras-induced transformation (f ± j) of NIH3T3 cells. NIH3T3 ®broblasts grown in tissue culture dishes (10 cm) were cotransfected with v-raf or H-ras plasmid and control plasmid (a,f), B59 (b,g), B23 (c,h) 3CH134 (d,i) or VHR (e,j) and grown under conditions selecting two dierent markers for 3 weeks.
Plates were ®xed and stained with methylene blue
Discussion
In this report we describe the isolation of a cDNA encoding a novel human protein, B59, and the characterization of its biological properties. The primary structure of B59 is similar to several dsPTPs; over a 70 amino acid stretch surrounding the HC motif, B59 shows signi®cant similarity to the human ERK PTPs B23 (Ishibashi et al., 1994) , CL100 (Alessi et al., 1993) and PAC1 (Rohan et al., 1993) . The 21-residue stretch including and extending C-terminal to the HC motif is the most conserved region among these related enzymes (reviewed in Denu et al., 1996) . N-terminal to this region, B59 contains a 48 amino acid stretch (residues 141 ± 189) that is highly enriched (37%) for serine. Within this region are three XSP motifs (B59 residues 143 ± 145, 147 ± 149, and 183 ± 185), which are putative sites for recognition by proline-directed serine kinases (reviewed in Marshall, 1995) . Upstream of this region, B59 contains the dual phosphorylation motif TEY (B59 residues 129 ± 131) found in ERK1 and ERK2 that is responsible for the activation of their kinase activities by MEK (Crews et al., 1992) . A search of protein sequences in GenBank revealed that this motif is found in several proteins that are unlikely to be MEK substrates. However, its presence in an ERK PTP is intriguing and the possibility that these residues are phosphorylated in B59 is currently being investigated. Northern analysis using a B59 cDNA probe revealed the presence of a single transcript of approximately 4.0 kb widely distributed in adult human tissues, with highest levels of expression in skeletal muscle and brain. This expression pattern was generally similar to that of B23, which was most highly expressed in pancreas and brain. Other ERK PTPs, such as CL100, its murine homolog 3CH134 and PAC1 appear to have more limited distributions. 3CH134 is highly expressed in lung (Charles et al., 1992) , displays elevated expression in ®broblast cell lines following serum treatment, oxidative stress, or heat shock, and the encoded dsPTP has a short half-life (Charles et al., 1992 . PAC1 is expressed in phytohaemagglutinin activated T-cells and Jurkat cells, spleen and thymus tissue (Rohan et al., 1993) .
While this work was in progress a novel rat dsPTP was discovered independently by two groups, designated rVH6 by Mourey et al. (1996) and MKP-3 by Muda et al. (1996) . The discovery of a human dsPTP designated Pyst1, the presumed homolog of rat rVH6/MKP-3, was reported soon after by Groom et al. (1996) . Amino acid sequence comparison of rVH6, MKP-3 and Pyst1 with B59 showed about 70% identity over the entire coding sequence. Over a 148 amino acid region encompassing the HC motif (residues 194 ± 342 of the B59 sequence), B59 and rVH6/MKP-3/Pyst1 show about 89% sequence identity. The N-and C-terminal¯anking regions share approximately 58% and 50% identity, respectively. Mourey et al. observed that rVH6 contains two nuclear export motifs, LXLXLXXL and LXXLXLXXL in its N-terminal region, similar to those identi®ed in the heatstable inhibitor of cAMP-dependent protein kinase and REV, an RNA binding protein of HIV-1 (Fischer et al., 1995; Wen et al., 1995) . Coincidentally, and unlike PAC1 (Rohan et al., 1993) , 3CH134 (Brondello et al., 1995) , hVH2 (Guan and Butch, 1995) and hVH3 (Kwak and Dixon, 1995) , which have been localized to the nucleus, rVH6/MKP-3 and Pyst1 were localized to the perinuclear cytosol (Mourey et al., 1996; Muda et al., 1996; Groom et al., 1996) . One of these putative nuclear export signals (amino acid residues 103 to 110) is also present in B59, although the subcellular localization of B59 has not yet been determined. Mourey et al. (1996) and Groom et al. 1996) each also reported the isolation of cDNA fragments encoding portions of putative dsPTPs related to MKP-3 and Pyst1, designated MKP-X and Pyst2, respectively. The human cDNA fragment Pyst2 encodes a protein that is 73% identical to Pyst1 protein, and completely identical to the C-terminal 320 amino acids of B59 (Groom et al., 1996) . Within this 320 amino acid region, the protein encoded by the cDNA fragment MKP-X diers from B59 by only six amino acids, suggesting that it may be the rat homolog of B59. Similarities in primary sequence between B59, Pyst1, and their presumed rat homologs MKP-X and rVH6/MKP-3, as well as common biological properties, suggest that these enzymes are more closely related to each other than to other known ERK dsPTPs. Like B59, rVH6/MKP-3 and Pyst1 exhibited a wide distribution of expression as determined by Northern blot analysis (Mourey et al., 1996; Muda et al., 1996; Groom et al., 1996) . Interestingly, the rVH6/MKP-3 transcript was induced in PC-12 cells following nerve growth factor-mediated dierentiation, but not in response to mitogenic stimulation by insulin (Mourey et al., 1996) or epidermal growth factor (Mourey et al., 1996; Muda et al., 1996) . Pyst1 mRNA levels were also found to be unresponsive to serum, heat shock, and oxidative stress (Groom et al., 1996) . Consistent with these observations, we found that B59 expression was not induced in human ®broblasts by either serum stimulation or heat shock (data not shown).
We compared the relative abilities of B59, B23, VHR and 3CH134 to dephosphorylate ERKs in an assay system similar to that used by Alessi et al. (1993) , and observed that each dsPTP, with the exception of VHR, eciently dephosphorylated ERK1 or ERK2. These results are consistent with published reports of ERK dephosphorylation in vitro by CL100 and 3CH134 (Alessi et al., 1993; Zheng and Guan, 1993; Charles et al., 1993) , PAC1 (Ward et al., 1994) and B23 (Ishibashi et al., 1994) and by 3CH134 and PAC1 (Chu et al., 1996) expressed transiently in COS cells. Using a simple mixture of puri®ed bacterially expressed recombinant proteins, we found previously that puri®ed VHR protein could dephosphorylate ERK1 protein in vitro (Ishibashi et al., 1994) . However, in that report, the concentrations of both enzyme and substrate were substantially higher than those used in present assay system. Thus the present ®ndings are most likely to re¯ect biologically relevant substrate selectivity, and VHR may indeed prefer other non-ERK family substrates which remain to be identi®ed. The H-ras oncogene product is thought to activate raf kinase, MEK kinase, and the ERKs (reviewed in Marshall, 1995) . Dominant negative mutants of MEK or ERKs inhibit H-ras driven NIH3T3 transformation and PC12 cell dierentiation, suggesting that signal transduction by H-ras protein requires ERK activation (Cowley et al., 1994) . Our present studies show that ectopic expression of B59, B23 or 3CH134 inhibited the rafBXB driven activation of an oncogeneresponsive reporter plasmid, while under the same conditions, VHR expression did not. Moreover, cotransfection of NIH3T3 ®broblasts with either B59, B23 or 3CH134 dsPTPs together with either H-ras or v-raf oncogenes dramatically suppressed the transforming activities of the latter. Thus B59 exhibits the functional properties displayed by a subfamily of dsPTPs that selectively target ERK family members, and that by maintaining ERKs in a dephosphorylated state, eectively block the H-ras or v-raf signals required for cellular transformation. The high level of sequence identity between B59 and Pyst1 and the dierences between these and other ERK-selective dsPTPs regarding transcriptional regulation, distinguish them from other ERK-selective dsPTPs, and may portend other functional dierences among these new dsPTP subfamilies.
Materials and methods
Molecular cloning and DNA sequence analysis
A 231bp DNA fragment from the catalytic domain of 3CH134 was generated from a mouse ®broblast cDNA library (Clontech, Inc.) using the polymerase chain reaction (PCR) as described previously (Ishibashi et al., 1994) . This probe was used to screen a human placenta cDNA library (Clontech, Inc.) under low stringency hybridization conditions (Kraus and Aaronson, 1991) , which resulted in the isolation of a partial cDNA encoding a novel putative PTP. This partical cDNA was in turn used as a probe to screen 8610 5 plaques from a B5/589 mammary epithelial cell cDNA expression library in lpCEV27 (Miki et al., 1991) under reduced stringency conditions (Kraus and Aaronson, 1991) . Plasmids carrying cDNA inserts were rescued from the isolated phagemid clones as described previously (Miki et al., 1989) . Digestion of a 3.0 kb cDNA by SalI and PstI yielded three DNA fragments of 0.3, 0.7, 1.1 and 1.3 kb, which were subcloned into pUC18 and used for sequence analysis. Double-stranded plasmid DNAs were sequenced in both directions by the dideoxy termination method (Sanger et al., 1977) using T7 polymerase (United States Biochemical, Inc.). Sequence comparisons were performed using the BLAST program (Altschul et al., 1990) . Sequences of dsPTPs were aligned using the PILEUP program (Deveraux, 1992) .
Expression plasmids
pCEV-B23 was prepared as described previously (Ishibashi et al., 1994) . pCEV-3CH134 and pCEV-VHR were constructed by ligation of 3CH134 and VHR cDNAs into the pCEV27 expression vector (Miki et al., 1989) . pRSVrafBXB and pB4X were generously provided by Dr Ulf Rapp. pB4X contains four AP1 binding sites upstream of the b-globin promoter fused to a chloramphenicol acetyltransferase (CAT) reporter gene. pSV-CAT was obtained from Stratagene, Inc.
Cell culture and transfection NIH3T3 ®broblasts were cultured in Dulbecco's Modi®ed Eagle's medium (DMEM) supplemented with 5% calf serum. DNA transfections were performed by precipitation with calcium phosphate using 1.5610 5 cells per culture dish (10 cm). Stable transfectants were selected for three weeks with appropriate antibiotics. In the focus formation assay, foci were counted after 2 and 3 weeks of transfection from non-selected plates. The number of transfectants was obtained from selected plates to normalize for transfection eciency. In cotransfection experiments designed for CAT activity assays, 1 mg of reporter plasmid (pB4X) and 5 mg each of pRSV-rafBXB and dsPTP expression plasmids was used. CAT activity was measured using a CAT ELISA kit (Boehringer-Mannheim, Inc.) after 48 h of transfection.
In vitro expression and ERK phosphatase assay B59 protein was synthesized by in vitro transcription and translation using the TNT rabbit reticulocyte lysate according to the manufacturer's protocol (Promega, Inc.) . Approximately 1 mg of each cDNA in pCEV27 was added to TNT reticulocyte lysate and transcribed by SP6 RNA polymerase. Protein synthesis was con®rmed by SDSpolyacrylamide gel electrophoresis (SDS ± PAGE) analysis of 35 S-methionine-labeled protein. The reticulocyte lysate containing B59 or other PTPs was mixed with Xenopus oocyte protein extract containing v-mos kinase at a ratio 1 : 1 (vol:vol). Puri®ed rat ERK1 or ERK2 proteins were added to the mixed lysates and after incubation for 20 min at 378C. The reaction was stopped by adding SDS ± PAGE sample buer and boiling for 3 min. Samples were resolved by SDS ± PAGE, transferred to polyvinylidine di¯uoride membranes (PVDF; Millipore, Inc.) and immunodetected with anti-ERK antibody (Upstate Biotechnology, Inc.).
Northern blot analysis
A`multiple tissue Norther blot' (Clontech, Inc.) was used for tissue distribution analysis. The ®lter was hybridized to a 3.0 kb B59 cDNA probe that had been labeled with [ 32 P]dCTP by the random primer method. Hybridization and washing conditions were described previously (Kraus and Aaronson, 1991) .
